C12N 2310/141
Micrornas, mirnas
Official title: MicroRNAs, miRNAs
C12N2310/141 (Micrornas, mirnas) appears on 1,680 US grants and 3,208 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,680
- Published applications
- 3,208
- Assignees
- 1,147
- Inventors
- 5,038
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 3 |
| 2005 | 0 | 10 |
| 2006 | 0 | 7 |
| 2007 | 2 | 5 |
| 2008 | 1 | 13 |
| 2009 | 1 | 61 |
| 2010 | 19 | 71 |
| 2011 | 13 | 90 |
| 2012 | 41 | 146 |
| 2013 | 74 | 127 |
| 2014 | 85 | 160 |
| 2015 | 112 | 231 |
| 2016 | 129 | 216 |
| 2017 | 129 | 201 |
| 2018 | 137 | 189 |
| 2019 | 131 | 205 |
| 2020 | 114 | 215 |
| 2021 | 122 | 248 |
| 2022 | 121 | 205 |
| 2023 | 105 | 200 |
| 2024 | 94 | 217 |
| 2025 | 122 | 247 |
| 2026 | 128 | 141 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement6 Oct 2026US 12,753,411 B2The Brigham and Women S Hospital, Inc.
- Methods of activating cells via PTP 1B inhibition29 Sep 2026US 12,746,285 B2Monash University
- Compositions and methods for reprogramming age-restricted non-neuronal cells29 Sep 2026US 12,747,438 B2The Regents of the University of California
- Nutritional composition comprising miR-312629 Sep 2026US 12,747,439 B2Societe des Produits Nestle S. A.
- Riboswitch modulated gene therapy for retinal diseases29 Sep 2026US 12,747,441 B2The Medical College of Wisconsin, Inc.
- Modified adeno-associated virus vector and use thereof in treating neurological diseases8 Oct 2026US 2026/0306673 A1Genecombio Ltd.
- Extracellular vesicles8 Oct 2026US 2026/0308526 A1VivaZome Therapeutics Pty Ltd
- Identification of host factors and compounds to boost viral transduction8 Oct 2026US 2026/0308589 A1University of Massachusetts
- An intelligent charge switchable polymer-lipid hybrid system for in vivo delivery of molecules including rnas1 Oct 2026US 2026/0294830 A1Qurcan Therapeutics Inc.
- Use of nucleic acid molecule in preparation of drug for treating liver disease1 Oct 2026US 2026/0297576 A1Guangxiu-Gaoxin Life Sciences Co., Ltd. Hunan
Most cited
By later US patents
- Methods and compositions involving miRNA and miRNA inhibitor molecules171US 9,506,061 B2Asuragen, Inc. · 2016
- MicroRNA molecules169US 7,232,806 B2MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V · 2007
- Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof154US 7,655,785 B1Rosetta Genomics Ltd. · 2010
- Oligomeric compounds and compositions for use in modulation of small non-coding RNAs132US 7,683,036 B2Regulus Therapeutics Inc. · 2010
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015